Infectious Diseases (all articles)
‘Everyone was left to guess what went wrong’: An open letter to AstraZeneca’s CEO on transparency
10 Sep, 2020 | 09:40h | UTC
Commentary on Twitter
Opinion: "In the middle of a pandemic — when the whole world, literally, is hoping a useful vaccine is on the horizon — everyone was left to guess what went wrong and what it might mean," @Pharmalot writes. https://t.co/jOpMyxC1dQ
— STAT (@statnews) September 9, 2020
Characteristics, comorbidities, and outcomes in a multicenter registry of patients with HIV and Covid-19
10 Sep, 2020 | 09:38h | UTC
Commentary on Twitter
🔥REDCap Data 🔥
A new multicenter registry
Severe clinical outcomes occurred commonly in people with HIV& #COVID19
The risk for poor outcomes was higher in those with comorbidities & lower CD4 cell counts, despite HIV viral suppression. @dr_dimadandachi https://t.co/Mg9lZgYxZy pic.twitter.com/GhBAD2ynqs— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 9, 2020
Link between fluoroquinolones, aorta problems may not be as strong as thought
10 Sep, 2020 | 09:31h | UTCLink between fluoroquinolones, aorta problems may not be as strong as thought – CIDRAP
Original Studies: Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection – JAMA Internal Medicine AND Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection
WHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide
10 Sep, 2020 | 09:27h | UTCWHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide – World Health Organization
Report: Global report on the epidemiology and burden of sepsis – World Health Organization
Commentary on Twitter
Today the first Global report on #sepsis was launched, offering the most comprehensive evidence on the life-threatening condition
👉 https://t.co/sSLSPAQFv8 pic.twitter.com/iCv4n2Ux9n
— World Health Organization (WHO) (@WHO) September 9, 2020
Interactive calculator for interpreting Covid-19 antibody test results
9 Sep, 2020 | 09:12h | UTCTesting for SARS-CoV-2 antibodies – The BMJ
Commentary on Twitter
#BMJInfographic Try out this new interactive calculator for interpreting covid-19 antibody test results @will_s_t https://t.co/t0Ha5zMlg1 pic.twitter.com/TAjVLog3A1
— The BMJ (@bmj_latest) September 8, 2020
Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine”
9 Sep, 2020 | 09:39h | UTC
Commentary on Twitter
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths. #COVID19 #SARSCoV2
— NEJM (@NEJM) September 8, 2020
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
9 Sep, 2020 | 09:45h | UTC
Commentary on Twitter
BREAKING: AstraZeneca's #Covid19 vaccine trials have been paused as the company investigates a serious adverse event the occurred in the UK. Not clear if the unexplained illness is linked to the vaccine, or what it was. https://t.co/wGqvvXIBTD
— Helen Branswell 🇨🇦 (@HelenBranswell) September 8, 2020
Drug companies seek to reassure the public about Covid-19 vaccine safety
9 Sep, 2020 | 09:43h | UTCSee also: 9 Drugmakers Sign Safety Pledge In Rush To Develop Coronavirus Vaccine – NPR AND U.S., European COVID-19 vaccine developers pledge to uphold testing rigour – Reuters
[Preprint] Randomized trial: Convalescent plasma not associated with improved outcomes in Covid-19
9 Sep, 2020 | 09:41h | UTC
Commentary on Twitter
Convalescent Plasma Randomized Controlled Trial (PLACID Trial) in the Management of Moderate #COVID19 (pre-print)
👉 “not associated with reduction in mortality or progression to severe COVID-19”
Link: https://t.co/2ZXnfemsas@GermHunterMD @MackayIM @CT_Bergstrom #IDTwitter pic.twitter.com/yZuOxVhbjL
— Alvin (@alvie_barr) September 8, 2020
The coronavirus is mutating — does it matter?
9 Sep, 2020 | 09:35h | UTCThe coronavirus is mutating — does it matter? – Nature
The immunology of multisystem inflammatory syndrome in children with COVID-19
9 Sep, 2020 | 09:33h | UTCThe Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 – Cell
Review: Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19
9 Sep, 2020 | 09:30h | UTC
IDSA Guidance on the treatment of antimicrobial resistant gram-negative infections
9 Sep, 2020 | 09:24h | UTCNews Release: IDSA Releases Guidance On Treatment Of Antimicrobial-Resistant Infections
Commentary on Twitter
The new @IDSAInfo guidance document on the treatment of MDR GN infections is 🔥🔥🔥. This a really practical/pragmatic document and will be of great use to frontline clinicianshttps://t.co/Eoz2vEHppb
— Mike Stevens (@Dr_Mike_Stevens) September 8, 2020
IDSA Podcast: The global health impact of COVID-19
9 Sep, 2020 | 09:26h | UTCThe Global Health Impact of COVID-19 – Infectious Diseases Society of America
Commentary on Twitter
NEW PODCAST 🎙️ "The Global Health Impact of COVID-19"
Listen: https://t.co/Su7sJNq8CZ @CDCgov global health experts Dr. Barbara Marston & Dr. Nancy Knight join us to discuss the agency’s role in responding to the COVID-19 pandemic globally. @CDCGlobal pic.twitter.com/NowVQ301xU
— IDSA (@IDSAInfo) September 8, 2020
Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination
9 Sep, 2020 | 09:37h | UTC
Commentary on Twitter
People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when a vaccine will be available to people like them, and when uptake will be high enough to enable a return to prepandemic life. #COVID19
— NEJM (@NEJM) September 8, 2020
Guidelines for the management of intravascular catheters in the ICU
9 Sep, 2020 | 09:22h | UTC
Perspective – Let’s get real. No vaccine will work as if by magic, returning us to ‘normal’
8 Sep, 2020 | 01:22h | UTCLet’s get real. No vaccine will work as if by magic, returning us to ‘normal’ – The Guardian
WHO: Emergency use approval is a “temporary solution,” countries should wait for large clinical trials to finish to roll out a COVID-19 vaccine en masse
8 Sep, 2020 | 01:21h | UTC
An ethical framework for global vaccine allocation
8 Sep, 2020 | 01:24h | UTCAn ethical framework for global vaccine allocation – Science
Commentary: Who should get the COVID-19 vaccine first? – University of Pennsylvania School of Medicine
Commentaries on Twitter
How would #COVID19 vaccines be distributed fairly across the globe once they are made available? Prominent philosophers and bioethicists outline the "Fair Priority Model", a 3-phase plan for vaccine distribution in @ScienceMagazine. https://t.co/1gdErzkRRh
— Stanford Ethics (@StanfordEthics) September 7, 2020
A new, three-phase plan for vaccine distribution for #COVID19—called the Fair Priority Model—is “the best embodiment of the ethical values of limiting harms…and recognizing equal concern for all people,” argues this #SciMagPolicyForum. Learn more: https://t.co/WKMvqKgDjl
— Science Magazine (@ScienceMagazine) September 7, 2020
Meta-analysis: Diagnostic characteristics of serological-based COVID-19 testing
8 Sep, 2020 | 01:16h | UTCSource: EvidenceAlerts
Evolution of the COVID-19 vaccine development landscape
8 Sep, 2020 | 01:18h | UTCEvolution of the COVID-19 vaccine development landscape – Nature Reviews Drug Discovery
Can you catch COVID-19 from your neighbor’s toilet?
8 Sep, 2020 | 01:12h | UTCCan you catch COVID-19 from your neighbor’s toilet? – Science
COVID-19 is, in the end, an endothelial disease
8 Sep, 2020 | 01:11h | UTCCOVID-19 is, in the end, an endothelial disease – European Heart Journal
Commentary on Twitter
COVID as an infectious disease of the “endothelium”, the lining of blood vessels, transmitted pre-sympyomatically. Explains the sepsis syndrome; explains the clotting/bleeding; explains the kidney failure.
What a nasty, nasty disease.https://t.co/5hlfL5Iik9
— David Fisman (@DFisman) September 7, 2020
Meta-analysis: Chloroquine and Hydroxychloroquine do not improve outcomes in COVID-19
8 Sep, 2020 | 01:08h | UTCRelated Meta-analysis: Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis – Arthritis & Rheumatology
Coalition Covid-19 Brazil – Randomized trial: Azithromycin not beneficial for patients admitted to the hospital with severe Covid-19
6 Sep, 2020 | 22:06h | UTCInvited Commentary: Azithromycin for severe COVID-19
Commentaries on Twitter
This network of Brazilian researchers has done an AMAZING job of getting organized & answering important ?s. In this Lancet article they show in a randomized trial that #azithromycin does not improve #Covid19 outcomes. @RenatoDLopes1 https://t.co/zL7GSaVqm8
— C. Michael Gibson MD (@CMichaelGibson) September 5, 2020
New trial @TheLancet does not support the routine use of azithromycin in combination with #Hydroxychloroquine in patients with severe #COVIDー19:https://t.co/vaj1XX3dSo
— Madhu Pai, MD, PhD (@paimadhu) September 6, 2020